Bioelectronics Corp (BIEL)

[Simpsonly]

Hey ImRich and Fuente - do you have any thoughts on what the pps may reach if just ALLAY were to receive FDA OTC approval before ActiPatch? I hope I'm not jumping the gun here, just curious.
The ActiPatch for strains, sprains, bruising etc., etc is one thing, but I have long seen ALLAY for women as a potential goldmine for both consumers suffering from medium to severe menstrual cramping and the company. Then I think of every pharmacy in the US..... That might mean we get P&G into the game (Tampax & Tampons) as well as J&J - Tylenol, etc.
I only have the data I read on the website, but it does not seem much of a leap given that the company has had approval for years for its RecoveryRx for post-op eye surgery applications. The costs to society resulting from female issues are in the billions of dollars in terms of lost work days and lowered productivity, without even considering women suffering monthly and the ripple effects of those close to them at in the workplace and elsewhere. If women could be drug/chemical free for these issues, I see that as huge potential. The market is immense here in the US and beyond and I guess ALLAY could be identified as a consummable, month after month after month.
Thanks for any thoughts you may have.